PCV105 COST-EFFECTIVENESS OF GENEOTYPE-GUIDED DOSING OF SHORTTERM USE OF WARFARIN AMONG DVT/PE PATIENTS
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74632-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)74632-5/fulltext
Title :
PCV105 COST-EFFECTIVENESS OF GENEOTYPE-GUIDED DOSING OF SHORTTERM USE OF WARFARIN AMONG DVT/PE PATIENTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74632-5&doi=10.1016/S1098-3015(10)74632-5
First page :
Section Title :
Open access? :
No
Section Order :
555